PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsShield Therapeutics
Shield Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AccruferFerric maltol2019-07-252031-2035
Iron-deficiency anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ferric maltol
colonic neoplasms
,
heart failure
,
anemia
,
iron-deficiency anemia
,
iron deficiencies
Aspartame
acne vulgaris
Nepidermin
lung neoplasms
,
healthy volunteers/patients
,
respiratory tract diseases
,
pleural effusion
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
neoplasms by site
,
malignant pleural effusion
,
pleural diseases
,
pleural neoplasms
,
neoplasms
,
breast neoplasms
,
adenocarcinoma of lung
,
colorectal neoplasms
,
brain neoplasms
,
neoplasm metastasis
,
inflammatory breast neoplasms
,
anus neoplasms
,
psoriasis
,
type 2 diabetes mellitus
,
diabetes mellitus
,
thromboembolism
,
venous thromboembolism
,
stroke
,
hepatitis c
,
hepatitis
,
hepatitis a
,
heart failure
,
schizophrenia
,
obesity
,
adenocarcinoma
,
carcinoma
,
squamous cell carcinoma
,
replacement arthroplasty hip
,
replacement arthroplasty knee
,
renal insufficiency
,
head and neck neoplasms
,
hyperglycemia
,
chronic hepatitis c
,
non-hodgkin lymphoma
,
hypertension
,
respiratory distress syndrome
,
neurogenic urinary bladder
,
covid-19
,
ischemic stroke
,
ischemia
,
liposarcoma
,
squamous cell carcinoma of head and neck
,
overweight
,
bronchiectasis
,
non-small-cell lung carcinoma
,
erbb-1 genes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use